Vanguard Reports 0 Shares of Neogen in 13G/A
The Vanguard Group filed Amendment No. 15 to a Schedule 13G/A reporting 0 shares of Neogen Corp, representing 0% beneficial ownership.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 15 to a Schedule 13G/A reporting 0 shares of Neogen Corp, representing 0% beneficial ownership. The amendment notes an internal realignment on January 12, 2026 under SEC Release No. 34-39538 that led certain Vanguard subsidiaries and business divisions to report holdings separately. The filing states those subsidiaries pursue the same investment strategies and that The Vanguard Group, Inc. no longer is deemed to beneficially own securities reported by those entities. The form lists the issuer address as 620 Lesher Place, Lansing, MI, and is signed by Ashley Grim on 03/27/2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Does The Vanguard Group report any beneficial ownership in NEOG?
What caused Vanguard to report zero NEOG ownership on the amendment?
Who signed the Schedule 13G/A amendment for NEOG?
Do Vanguard subsidiaries still follow the same investment strategies after realignment?
Is any third party identified as having rights to NEOG dividends or proceeds?
AI-generated analysis. How Rhea-AI works. Not financial advice.